GlaxoSmithKline fined $3 bn in US

"The headquarters Glaxo Smith Kline (GSK) in west London. GlaxoSmithKline was socked with $3 billion in fines by US authorities over charges it marketed drugs for unauthorized uses, held back safety data, and cheated the government's Medicaid program. (AFP Photo/Odd Andersen)" title

View the Original article